Geron (GERN) Other Operating Expenses (2010 - 2026)
Geron's (GERN) quarterly Other Operating Expenses came in at -$48.3 million in Q1 2026, up 10.39% year-on-year from -$43.7 million in Q1 2025, and up 78.95% quarter-over-quarter from -$229.4 million in Q4 2025.
Geron (GERN) Other Operating Expenses (2010 - 2026) Analysis & Trends
Geron has disclosed Other Operating Expenses across 6 years of filings, most recently posting -$48.3 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$48.3 million, up 10.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$335.5 million (down 8931.69% YoY), and the FY2025 annual result was -$243.0 million, down 19445.22% from the prior year.
- Other Operating Expenses came in at -$48.3 million for Q1 2026 at Geron, up from -$229.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $183.4 million in Q4 2024 to a low of -$229.4 million in Q4 2025.
- The 3-year median for Other Operating Expenses is -$55.6 million (2024), against an average of -$43.1 million.
- Peak annual rise in Other Operating Expenses reached 101.7% in 2025, while the deepest fall reached 225.04% in 2025.
- Geron's Other Operating Expenses stood at $183.4 million in 2024, then tumbled by 225.04% to -$229.4 million in 2025, then surged by 78.95% to -$48.3 million in 2026.
- The last three Other Operating Expenses figures came in at -$48.3 million (Q1 2026), -$229.4 million (Q4 2025), and -$59.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Geron | 753,046.88 | 753,046.88 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.30 Mn |
| Dec 31, 2025 | -229.38 Mn |
| Sep 30, 2025 | -59.03 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | -53.90 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Sep 30, 2024 | -55.57 Mn |
| Jun 30, 2024 | -70.18 Mn |
| Mar 31, 2024 | -56.44 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2011 | 5.45 Mn |
| Dec 31, 2010 | 35.00 Mn |